Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Immune Technologies & Medicine GmbH |
---|---|
Information provided by: | Immune Technologies & Medicine GmbH |
ClinicalTrials.gov Identifier: | NCT00824980 |
The major objective of this study is to evaluate the therapeutic effect of a topical treatment simultaneously inhibiting Dipeptidyl Peptidase IV and Aminopeptidase N (IMTM #IP10.C8) in patients with mild to moderate psoriasis of the skin
Condition | Intervention | Phase |
---|---|---|
Psoriasis |
Drug: IP10.C8 |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Combined Inhibition of Dipeptidyl Peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/CD13) in the Treatment of Psoriasis - Phase II Single Center Study |
Estimated Enrollment: | 24 |
Study Start Date: | January 2009 |
Estimated Study Completion Date: | September 2009 |
Estimated Primary Completion Date: | September 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
IP10.C8 Gel: Experimental |
Drug: IP10.C8
IP10.C8 Gel 1%
|
Placebo Gel: Placebo Comparator |
Drug: IP10.C8
IP10.C8 Gel 1%
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Alexander Narvarini, M.D. | 41 (0)44 255 11 11 | alexander.navarini@usz.ch |
Switzerland | |
University Hospital Zurich | Recruiting |
Zurich, Switzerland, 8091 | |
Contact: Alexander Navarini, Dr.med. Dr.sc.nat. 41 (0)44 255 11 11 alexander.navarini@usz.ch |
Principal Investigator: | Lars E French, Prof. | University Hospital Zurich Department of Dermatology / Gloriastrasse 31 |
Responsible Party: | Dermatologische Klinik, Gloriastrasse 31, USZ, CH-8091 Zürich ( Curdin Conrad, M.D. ) |
Study ID Numbers: | IMTM_IP10.C8_II/1 |
Study First Received: | January 16, 2009 |
Last Updated: | January 16, 2009 |
ClinicalTrials.gov Identifier: | NCT00824980 History of Changes |
Health Authority: | Switzerland: Swissmedic |
Skin Diseases Psoriasis Skin Diseases, Papulosquamous |
Skin Diseases Psoriasis Skin Diseases, Papulosquamous |